Comparison of transcatheter, sutureless and conventional aortic valve replacement

Keywords: rapid deployment valve; transcatheter valve; aortic valve replacement; aortic stenosis

Recent clinical trials have demonstrated that transcatheter and sutureless aortic valve replacement (AVR) are non-inferior to conventional AVR in high-risk patients; however, data comparing perioperative outcomes of the three techniques are lacking.

This summary reports the results of a Bayesian network analysis of seven randomised controlled trials and 25 propensity-matched studies comparing the techniques. Lloyd et al. investigated mortality, stroke, myocardial infarction, major bleeding, paravalvular regurgitation, acute kidney injury and pacemaker implantation, to determine which technique (if any) offered the best outcomes.

Download below to keep up to date with the latest research in AVR.

PowerPoint Lloyd et al.

Click here to access the full publication in PubMed

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, EDWARDS INTUITY, EDWARDS INTUITY Elite, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.